LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
63.64
+0.56 (0.89%)
Dec 17, 2025, 10:13 AM EST - Market open
LivaNova Employees
LivaNova had 2,900 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,900
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$465,159
Profits / Employee
-$74,995
Market Cap
3.48B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,900 | 0 | - |
| Dec 31, 2023 | 2,900 | 0 | - |
| Dec 31, 2022 | 2,900 | -100 | -3.33% |
| Dec 31, 2021 | 3,000 | -1,000 | -25.00% |
| Dec 31, 2020 | 4,000 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LIVN News
- 14 days ago - LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting - Business Wire
- 15 days ago - LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea - Business Wire
- 22 days ago - LivaNova to Present at Piper Sandler Healthcare Conference in December - Business Wire
- 23 days ago - LivaNova's VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services - Business Wire
- 4 weeks ago - LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day - Business Wire
- 5 weeks ago - LivaNova PLC (LIVN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance - Business Wire
- 7 weeks ago - LivaNova to Present at Wolfe Research Healthcare Conference in November - Business Wire